Expertise in
6
conditions

Bjorn E. Wahlin

Stockholm, AB, SE 
Expertise in
6
conditions
Stockholm, AB, SE 

Overview

Bjorn Wahlin practices practicing medicine in Stockholm, Sweden.

Mr. Wahlin is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), Bone Marrow Transplant, and Splenectomy.

He is actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Stockholm, AB, Sweden
Other Locations
Solna, AB, Sweden
Huddinge, AB, Sweden
Umea, AC, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Rituximab With or Without Ibrutinib for Untreated Patients With Advanced Follicular Lymphoma in Need of Therapy. A Randomized, Double-blinded, SAKK and NLG Collaborative Phase II Trial.
Rituximab With or Without Ibrutinib for Untreated Patients With Advanced Follicular Lymphoma in Need of Therapy. A Randomized, Double-blinded, SAKK and NLG Collaborative Phase II Trial.
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drugs: Ibrutinib, Rituximab
Study Phase: Phase 2

83 Total Publications

Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial.
Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial.
Journal: The Lancet. Haematology
Published: April 28, 2026

Frequently Asked Questions about Bjorn E. Wahlin

Is Bjorn E. Wahlin a top-rated expert for Follicular Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Bjorn E. Wahlin is classified as an Elite expert for Follicular Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bjorn E. Wahlin participate in research or clinical trials?

Yes. Bjorn E. Wahlin has published 83 articles and abstracts on conditions like Follicular Lymphoma. You can view a list of Bjorn E. Wahlin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wahlin's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile